Skip to main content

ONO PHARMACEUTICAL CO., LTD.

  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • About
      About
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Corporate Slogan
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies
    • Company Profile
    • Management
    • Business Locations
    • ONO Story
    • R&D
    • Manufacturing
    • Activities for Disseminating Academic Information
    • Safety and Quality Assurance
    • Digital & IT
    • ONO’s 300-Year History
    • Videos and Advertisements Top
    • "Rising to the challenges of Immuno-Oncology"
    CLOSE
    ONO Story
    ONO Story
    Videos and Advertisements
    Videos and Advertisements
  • R&D
      R&D
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support
    • Licensing Activities Top
    • Licensing & Co-promotion
    • Drug discovery partnerships & Research collaborations
    CLOSE
    Development Pipeline
    Development Pipeline
  • Global Business
  • Sustainability
      Sustainability
    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
    • Commitment to Conservation of the Global Environment
    • Information Disclosure Based on the TCFD Recommendation
    • Realization of a Decarbonized Society
    • Realization of a Water Recycling-oriented Society
    • Realization of a Resource Recycling Society
    • Information Disclosure Based on the TNFD Recommendations
    • Biodiversity
    • EHS Management
    • Environmental Accounting
    • Innovative Pharmaceutical Products
    • Efforts Made for Improving Access to Healthcare
    • Respect for Human Rights
    • Expansion of Human Capital (Talent Development)
    • Expansion of Human Capital (DE&I)
    • Cultivation of Employee-friendly Workplaces/Safety and Health
    • Supply Chain Management
    • Corporate Governance
    • Compliance
    • Risk Management
    • Responsible Promotion Activities
    • Stakeholder Engagement
    • Communication with Investors
    • Cooperation with Governments
    • Social Contribution Activities
    • Efforts for the Advancement of Medicine and Pharmacy
    • Efforts for Supporting Health of Patients and Their Families
    • Efforts Toward Environmental Conservation for the Health of Everyone
    • Efforts Toward an Education for the Children’s Health
    • Efforts for Improvement of the Medical Ecosystem
    CLOSE
    ECO VISION 2050
    ECO VISION 2050
    Improving Access to Healthcare
    Improving Access to Healthcare
icon_search_white icon_close_w
  • About
    • About Top
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Corporate Slogan
    • Company Overview
    • History
    • Main Products
    • Videos and Advertisements
    • Policies
    Business Activities
    • R&D
    • Manufacturing
    • Activities for Disseminating Academic Information
    • Safety and Quality Assurance
    • Digital & IT
  • R&D
    • R&D Top
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support
  • Global Business
    • Global Business Top
  • Sustainability
    • Sustainability Top
    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
icon_search_g
Home Investors Shareholder Information Shareholders' Meeting

Investors

  • Management Policy
  • Financial Highlights
  • IR Library
  • Shareholder Information
    • Shareholders' Meeting
    • General Stock Information
    • Shareholder Return Policy
    • Stock Price Chart
    • FAQ
  • Dialogue with Shareholders and Investors
  • IR Calendar
  • ESG Initiatives

Shareholders' Meeting

The 76th Ordinary General Shareholders’ Meeting

Notice of Convocation (310 KB)
Notice of Resolution (153 KB)
Voting Results (Extraordinary Report) (146 KB)

The 75th Ordinary General Shareholders’ Meeting

Notice of Convocation (363 KB)
Notice of Resolutions (152 KB)
Voting Results (Extraordinary Report) (217 KB)

The 74th Ordinary General Shareholders’ Meeting

Notice of Convocation (402 KB)
Notice of Resolutions (156 KB)
Voting Results (Extraordinary Report) (250 KB)

The 73rd Ordinary General Shareholedrs’ Meeting

Notice of Convocation (232 KB)
Notice of Resolutions (110 KB)
Voting Results (Extraordinary Report) (338 KB)

The 72nd Ordinary General Shareholedrs' Meeting

Notice of Convocation (196 KB)
Notice of Resolutions (108 KB)
Voting Results (Extraordinary Report) (251 KB)
  • Shareholders' Meeting
  • General Stock Information
  • Shareholder Return Policy
  • Stock Price Chart
  • FAQ
  • About

    About

    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Corporate Slogan
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies
  • R&D

    R&D

    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Policy
    • Development Pipeline
    • The investigator-sponsored research support
  • Global Business

    Global Business

  • Sustainability

    Sustainability

    • Top Message
    • ONO's Approach to Sustainability
    • Environment
    • Society
    • Governance
    • Stakeholder Engagement
    • Social Contribution Activities
    • Policies
    • GRI Standards Content Index
    • Sustainability Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • Privacy Policy
  • Terms of Use
  • Site Map

COPYRIGHT © 2025 ONO PHARMACEUTICAL CO., LTD.
ALL RIGHTS RESERVED.

GoTo Top